A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the ...
In a preclinical mouse study, gene therapy delivering VEGFC to kidney cells reduced early signs of kidney damage in Type 1 ...
A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious ...
Fractyl Health Inc. (NASDAQ:GUTS) is one of the best young stocks with huge upside potential. On October 7, Fractyl Health ...
HOUSTON, April 04, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending for the development of ...
A team of researchers at UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and potentially reverse, immune checkpoint inhibitor (ICI)–induced type I ...
Millions of people with type 1 or 2 diabetes worldwide rely on insulin injections or medications to keep their blood sugar in check. The disease results from the destruction of the pancreas’s finite ...
Staphylococcus aureus is a leading cause of antibiotic resistance-associated infections and deaths. It is also the most prevalent bacterial infection among individuals with diabetes mellitus (DM), a ...